Effect of phospholipids on the transformation of amorphous calcium phosphate to hydroxapatite in vitro.
The conversion of amorphous calcium phosphate (ACP) to crystalline hydroxyapatite (HA) was studied in vitro in the presence or absence of phosphatidyl serine (PS) and other phospholipids. ACP transformation and HA crystal growth were monitored by electron microscopy, selected-area electron diffraction and X-ray diffraction, and by measuring supernatant calcium and phosphate. PS, and other acidic phospholipids, had a significant stablizing effect on ACP. With performed ACP at ratios of only 1 lipid molecule per 30-50 Ca atoms, PS markedly delayed HA crystal formation. When PS was present during ACP precipitation, inhibition of conversion to HA was less pronounced, but crystal habit and aggregation were greatly altered resulting in stacks of thin, membrane-like sheets approximately 38-42 A thick. PS appeared to be most effective in blocking ACP to HA conversion when oriented primarily on the surface; it most affected subsequent crystal formation when distributed throughout the amorphous precursor. Phospholipids possessing anionic, and hence Ca-binding properties, were effective in stabilizing ACP; neutral zwitterion lipids, which have amphipathic properties but do not bind Ca, were not. In view of the presence of anionic lipids in matrix vesicles and their association with early mineral deposits, the current findings add further evidence that lipids may play a role in the control of normal mineralization in vivo.
D002113:Calcification, Physiologic; D002130:Calcium Phosphates; D003460:Crystallization; D006882:Hydroxyapatites; D009113:Muramidase / Q000494:pharmacology; D010718:Phosphatidylserines / Q000494:pharmacology; D010743:Phospholipids / Q000494:pharmacology*
D002130:Calcium Phosphates; D006882:Hydroxyapatites; D010718:Phosphatidylserines; D010743:Phospholipids; C519480:amorphous calcium phosphate; D009113:Muramidase